FLCN - Falcon Technologies, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.1150
-0.0310 (-21.23%)
At close: 1:05PM EDT
Stock chart is not supported by your current browser
Previous Close0.1460
Open0.1150
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.1150 - 0.1150
52 Week Range0.0001 - 0.6300
Volume199
Avg. Volume17,499
Market Cap2.246M
Beta (3Y Monthly)10.32
PE Ratio (TTM)N/A
EPS (TTM)-0.0480
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • ACCESSWIRE5 days ago

    Dr. Tin-Chuen Yeung, Distinguished Former Director of Strategy and Business Development at Baxter Healthcare Accepts Position as Advisory Panel Member of Falcon Technologies

    SACRAMENTO, CA / ACCESSWIRE / June 11, 2019 / Falcon Technologies, Inc. (FLCN), a company focused on the marketing, sale, and distribution of CBD products and products derived from industrial hemp is honored Dr. Tin-Chuen Yeung has formally accepted a position on its Scientific Advisory Board. Dr. Yeung is a pharmacologist and an experienced researcher in the healthcare industry. Dr. Yeung is currently the President of Everest International, Inc., where he provides consulting services in management of intellectual property, patent filing and prosecution, intellectual property, due diligence for M&A's, technology licensing, technology commercialization, and business development.

  • ACCESSWIRE18 days ago

    Falcon Technologies Announces Formation of Scientific Advisory Panel

    SACRAMENTO, CA / ACCESSWIRE / May 29, 2019 / Falcon Technologies, Inc. (OTC PINK: FLCN) announced today that it has formed a Scientific Advisory Panel to guide the company in advanced product development, intellectual property protection, clinical research and licensing agreements as the company continues to unveil its business plan. The members of the company's Scientific Advisory Panel have unparalleled scientific expertise. Falcon Technologies is a public company focused on the marketing, sale, and distribution of CBD products and products derived from industrial hemp.

  • ACCESSWIRElast month

    Falcon Technologies Announces Its Participation and Attendance at the May 31, 2019 Food and Drug Administration Meeting for Products Containing Cannabis and Cannabis-Derived Compounds

    SACRAMENTO, CA / ACCESSWIRE / May 15, 2019 / Falcon Technologies, Inc. (OTC PINK: FLCN) announced today that a representative for Falcon Technologies, Inc. will be attending the May 31st Food and Drug Administration meeting for scientific data and information about products containing cannabis and cannabis-derived compounds. Falcon Technologies is a public company focused on the marketing, sale, and distribution of CBD products and products derived from industrial hemp. According to the Food and Drug Administration, the goal of the hearing is to obtain additional scientific data and other information related to cannabis and cannabis-derived compounds, both from botanical and synthetic sources, to inform our regulatory oversight of these products.

  • ACCESSWIRElast month

    Falcon Technologies Adds CBD Transdermal Sports Patch to Planned Product Line

    SACRAMENTO, CA / ACCESSWIRE / May 9, 2019 / Falcon Technologies, Inc. (OTC PINK: FLCN), a company focused on the marketing, sale, and distribution of CBD products and products derived from industrial hemp announced today that in addition to plans to launch other dermal-delivered CBD products, the company will launch the "CBD Transdermal Sports Patch XR". Over the past few months, Falcon has filed two provisional patents and is also advancing the planned product line for acne, psoriasis and rosacea. Central to Falcon's business plan is to develop CBD products that deliver therapeutic amounts of CBD with additional product formulation benefits to the customer.

  • ACCESSWIRE2 months ago

    Falcon Technologies Adds Eczema, Psoriasis, and Rosacea to Pending Skincare Product Line Targets

    SACRAMENTO, CA / ACCESSWIRE / April 26, 2019 / Falcon Technologies, Inc. (OTC PINK: FLCN), a company focusing on the marketing, sale, and distribution of CBD products and products derived from industrial hemp announced today that in addition to acne which affects 35 million Americans, the company's pending skincare product line will also target eczema, psoriasis and rosacea. The total market size for Falcon's skincare product line is in excess of 100 million Americans that suffer from acne, eczema, psoriasis and rosacea.

  • ACCESSWIRE2 months ago

    Falcon Technologies Announces the Filing of a Provisional Patent Application for CBD Formulations to Treat Ulcers

    SACRAMENTO, CA / ACCESSWIRE / April 25, 2019 / Falcon Technologies, Inc. (OTC PINK: FLCN) announced today that it has filed a provisional patent application with the United States Patent and Trademark Office. The invention is titled "CBD Formulations to Treat Peptic and Gastrointestinal Ulcers". Peptic ulcers can occur in the stomach, the intestines and even parts of the esophagus.

  • ACCESSWIRE2 months ago

    Falcon Technologies Comments on CVS Now Selling CBD Products in Select Stores in the United States

    SACRAMENTO, CA / ACCESSWIRE / April 17, 2019 / Falcon Technologies, Inc. (OTC PINK: FLCN), a company focusing on the marketing, sale, and distribution of CBD products and products derived from industrial hemp such as protein powder, hemp seeds and hemp oil has commented on the recent news that CVS began selling topical CBD products. Universally known as CBD, Cannabidiol (the scientific name for CBD) is one of at least 80 active cannabinoids identified in both cannabis and industrial hemp. The 2018 Farm Bill legalized industrial hemp, removing this plant rich in CBD and nutritional supplements from the Controlled Substance Act and categorizing it as an agricultural commodity.

  • ACCESSWIRE2 months ago

    Falcon Technologies Announces the Signing of an Exclusive 1 Year License of (2) CBD Related Domain Names for the Marketing, Sale and Distribution of its CBD Products

    SACRAMENTO, CA / ACCESSWIRE / April 15, 2019 / Falcon Technologies, Inc. (OTC PINK: FLCN) announced today that it has signed an exclusive worldwide license to use the domain names maximumstrengthcbd.com and extendedreleasecbd.com to market, sell and distribute its CBD products. The licensing agreement will provide Falcon with a competitive advantage over other companies selling CBD using the world side web. As part of the company's overall marketing strategy, Falcon is striving on a daily basis to be able to place its soon to be launched CBD products in front of as many consumers as possible.

  • ACCESSWIRE2 months ago

    Falcon Technologies Announces the Signing of an Exclusive 2 Year Worldwide License with Publicly-Traded Stevia Corp. to Sell, Market, and Distribute Hemp Products Using the Real Hemp(TM) Brand with an Option to Purchase

    SACRAMENTO, CA / ACCESSWIRE / April 10, 2019 / Falcon Technologies, Inc. (OTC PINK: FLCN) (OTC PINK: STEV) announced today that it has signed an exclusive worldwide license to use the Real Hemp™ trademark and brand to market, sell and distribute any dietary and nutritional supplements containing any constituents of the hemp plant for the next 2 years. As a result of the vision of Stevia Corp.'s Chairman George Blankenbaker, Real Hemp LLC (Stevia Corp.'s wholly owned subsidiary), achieved trademark status and full trademark registration on July 7, 2015 before the cultivation of hemp products became completely legal in the United States.

  • GlobeNewswire3 months ago

    NeutriSci Enters Into LOI With Falcon Technologies Inc. dba Eco-Growth Strategies to Manufacture Sublingual CBD Products

    NeutriSci has agreed to enter into this LOI with Falcon to create sublingual tablets for the delivery of dietary supplements including CBD in which these tablets can potentially create a product that has more efficient absorption rates than other CBD products. Upon the successful completion of a due-diligence period, both companies will work towards signing a definitive agreement in early Q2/2019.

  • ACCESSWIRE3 months ago

    Falcon Technologies aka Eco-Growth Strategies Enters Into LOI With Neutrisci To Manufacture Sublingual CBD Products

    SACRAMENTO, CA / ACCESSWIRE / March 25, 2019 / Neutrisci International Inc. (the "Company" or "NeutriSci") (TSX-V: NU, OTCQB: NRXCF, FRANKFURT: 1N9) the innovator and pioneer behind neuenergy®, and Falcon Technologies, Inc. ("Falcon") (FLCN:OTC PINK) are pleased to jointly announce they have entered into a Letter of Intent to create a sublingual CBD tablet. NeutriSci has agreed to enter into this LOI with Falcon to create sublingual tablets for the delivery of dietary supplements including CBD in which these tablets can potentially create a product that has more efficient absorption rates than other CBD products.

  • ACCESSWIRE3 months ago

    Falcon Technologies Announces the Filing of a Provisional Patent Application Titled ''CBD Formulations to Treat Acne''

    SACRAMENTO, CA / ACCESSWIRE / March 21, 2019 / Falcon Technologies, Inc. (OTC PINK: FLCN) announced today that it has filed a provisional patent application with the United States Patent and Trademark Office. The invention is titled ''CBD Formulations to Treat Acne''. As previously announced, the company expects to have its first products available for sale on or before April 30, 2019.

  • ACCESSWIRE3 months ago

    Falcon Technologies, Inc. (a/k/a Eco-Growth Strategies, Inc.) Announces Entry into the CBD Market

    The company's short-term focus will be on the marketing and sale of topical, high strength applications of CBD. Shortly thereafter, the company also plans on launching a high strength CBD hemp oil. The company expects to have its first products available for sale on or before April 30, 2019.